California healthcare marketing sits under the strictest state-level enforcement environment in the country - Medical Board of California rules, Business & Professions Code §17500 false advertising authority, and active AG consumer protection.
State-level overview
California is the single most-enforced state for healthcare marketing. The Medical Board of California (MBC) has its own detailed advertising rules in 16 CCR §1353.5; the Attorney General's office uses B&P §17200 and §17500 authority extensively against healthcare practices; and the state's Sherman Food, Drug, and Cosmetic Law mirrors federal FDA authority at state level. Practices marketing in California face a genuinely distinct and heavier regulatory surface than most states, and marketing written to 'meet federal rules' often still fails California-specific standards.
The MBC actively enforces 16 CCR §1353.5 - which covers deceptive advertising by licensed physicians. Specialty-claim misuse ('cosmetic surgeon' by non-ABMS-certified physicians), supervision misrepresentation (particularly for med spa injectors), and outcome guarantee language are the most common bases for discipline. California also has specific rules on how physicians can advertise 'board-certified' status - requiring disclosure of the specific certifying board.
The California AG uses Business & Professions Code §17500 (false advertising) and §17200 (unfair competition) extensively. Recent enforcement has focused on telehealth prescribing advertising (particularly for weight loss and hormones), package pricing disclosure in aesthetic practices, and medical device marketing that misrepresents FDA clearance status. California is also the origin of many multi-state healthcare marketing settlements.
Enforcement focus
California tightly regulates who can perform injectables and under what supervision. Marketing language implying nurse-injector independence ('book directly with your injector,' 'our expert injectors') has been cited by both MBC and DCA in multiple actions. Compliant framing requires explicit physician/NP/PA supervision disclosure.
Telehealth practices marketing in California must meet California telehealth standards regardless of where the prescribing provider is based. Marketing that minimizes evaluation steps ('script in 24 hours,' 'skip the doctor visit') has drawn direct AG attention.
California enforces the FDA-approved vs FDA-cleared distinction at state level via the Sherman Law. Aesthetic devices marketed as 'FDA-approved' when only cleared are exposed both federally and under California's parallel authority.
While the FTC Endorsement Guides apply federally, California's §17500 authority provides additional state-level exposure on before/after marketing without typical-experience disclosure.
Patterns we flag in California
'Book directly with [nurse injector name]' language on med spa sites
Why: MBC treats implied nurse independence as supervision misrepresentation even if supervision is in fact in place.
'FDA-approved' applied to FDA-cleared aesthetic devices
Why: Triggers both federal FDA misbranding and California Sherman Law violations - double exposure.
Telehealth prescriber location not disclosed
Why: California AG has pursued telehealth practices for not clearly disclosing where the prescribing provider is actually located.
Package pricing advertising without clear add-on disclosure
Why: California AG active enforcement area - particularly in aesthetic surgery and fertility practices.
Patient testimonials with outcome specificity and no typical-experience disclosure
Why: §17500 provides state-level authority to pursue patterns federal FTC may not get to first.
By specialty
By specialty in California
Specialty rules stack on top of state rules. Find the specialty-specific framework that applies to your practice.
Disclaimer
This summary reflects general patterns in California healthcare marketing enforcement; it is not legal advice. For state-specific guidance on your practice, consult a California-licensed healthcare marketing attorney.
RegenCompliance applies federal FDA and FTC rules plus the most-enforced state patterns automatically. California-specific language is part of the rule set.
Other state guides
See allTexas has an active Medical Board with specific rules for medical advertising, and the DTPA gives consumers and the state AG independent enforcement authority over deceptive healthcare marketing.
Read state guideFlorida's regulatory environment is defined by the Board of Medicine, FDUTPA, and an AG office that has been active on healthcare marketing - particularly in the fast-growing med spa, weight-loss, and regen categories.
Read state guideNew York's healthcare marketing environment is defined by OPMC, an aggressive AG office, and the state's particularly strict corporate-practice-of-medicine rules - each of which shapes how practices can advertise.
Read state guide